Industry News — GLPbase

March 27, 2026

Men Are Injecting Peptides to Build Muscle and Recover Faster – But the Risks Are Real – Men’s Health

Recent developments regarding men are injecting peptides to build muscle and recover faster – but the risks are real - men's health have drawn attention fr

Source: Men's Health

GLP-1

March 27, 2026

Oral Alternative to Ozempic May Be Even More Effective For Weight Loss – ScienceAlert

Recent developments regarding oral alternative to ozempic may be even more effective for weight loss - sciencealert have drawn attention from the medical c

Source: ScienceAlert

GLP-1

March 27, 2026

GLP-1 agonists could be a global game-changer, but need to be accessible and affordable – Aidsmap

Recent developments regarding glp-1 agonists could be a global game-changer, but need to be accessible and affordable - aidsmap have drawn attention from t

Source: Aidsmap

Hormones

March 27, 2026

Hormone replacement therapy and menopause: What experts want you to know – NBC 5 Chicago

Recent developments regarding hormone replacement therapy and menopause: what experts want you to know - nbc 5 chicago have drawn attention from the medica

Source: NBC 5 Chicago

Peptides

March 27, 2026

The Rise of Peptide Therapy in India: Dr. Harikiran Chekuri Leads the Shift Toward Longevity Medicine – Telangana Today

Recent developments regarding the rise of peptide therapy in india: dr.

Source: Telangana Today

Peptides

March 26, 2026

Peptide Stacking Is Everywhere—But Should You Be Doing It? – Goop

The popular practice of combining multiple peptides lacks clinical evidence and raises safety concerns despite growing mainstream adoption.

Source: Goop

Aesthetics

March 26, 2026

Next-Generation Neurotoxins: What the ‘Godmother of Botox’ Says Is Coming Next – NewBeauty

Expert reveals next-generation neurotoxins promise faster results and longer-lasting effects for aesthetic treatments.

Source: NewBeauty

Hormones

March 26, 2026

HRT patches for menopause ‘can help treat prostate cancer’ – but there is one main side effect – The Independent

Menopause HRT patches show promise for prostate cancer treatment by suppressing testosterone, though they cause feminizing side effects.

Source: The Independent

GLP-1

March 26, 2026

Next gen GLP-1 drugs orforglipron and retatrutide: Your questions answered – Clarivate

Clarivate analyzes orforglipron and retatrutide, next-gen GLP-1 drugs offering oral delivery and triple-hormone action for diabetes and obesity.

Source: Clarivate

GLP-1

March 26, 2026

Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs – Johns Hopkins Bloomberg School of Public Health

Johns Hopkins study finds GLP-1 drugs improve heart and kidney outcomes in type 1 diabetes patients beyond blood sugar control.

Source: Johns Hopkins Bloomberg School of Public Health

Hormones

March 25, 2026

‘I couldn’t even count to 10’: The midlife women turning to testosterone to save their sanity – The Telegraph

Midlife women are seeking testosterone therapy for severe cognitive symptoms during menopause, including debilitating brain fog.

Source: The Telegraph

Peptides

March 25, 2026

Wellness peptide craze: Why people are injecting drugs ‘not for human consumption’ – BBC

Wellness seekers inject unregulated peptides marked "research only," bypassing safety testing despite serious health risks, BBC finds.

Source: BBC

GLP-1

March 25, 2026

Semaglutide Linked to Lower Suicidality Risk in Diabetes, With Mark Taylor, MD – HCPLive

New data suggests semaglutide may reduce suicide risk in diabetes patients, contrary to earlier safety concerns about GLP-1 medications.

Source: HCPLive

GLP-1

March 25, 2026

Oral Semaglutide Improves Cardiovascular Risk Factors in Type 2 Diabetes – AJMC

Oral semaglutide reduces cardiovascular risk factors in type 2 diabetes patients, offering effective protection in tablet form.

Source: AJMC

Peptides

March 25, 2026

‘I have the energy of a 21-year-old’: The peptide wellness boom taking over your social media – NZ Herald

Peptide wellness claims are surging on social media, with users reporting dramatic energy boosts despite limited evidence and regulatory oversight.

Source: NZ Herald

Peptides

March 25, 2026

Can Scorpion Venom Peptides Be Safely Used in Cardiovascular Therapy: A Systematic Review – Cureus

Systematic review explores safety of scorpion venom peptides for cardiovascular treatment, highlighting both promise and challenges.

Source: Cureus

GLP-1

March 25, 2026

Kendra Wilkinson Reveals Why She’s Starting GLP-1 Shots – Us Weekly

Kendra Wilkinson announced she's beginning GLP-1 treatment, adding to growing celebrity transparency about weight management medications.

Source: Us Weekly

Aesthetics

March 25, 2026

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign – PR Newswire

Allergan Aesthetics launches new BOTOX® Cosmetic campaign featuring authentic patient stories and real user experiences.

Source: PR Newswire

GLP-1

March 25, 2026

Could orforglipron reshape the GLP-1 market? – Managed Healthcare Executive

Eli Lilly's oral GLP-1 drug orforglipron could transform the market by offering a pill alternative to weekly injections.

Source: Managed Healthcare Executive

Exosomes

March 24, 2026

Exosome Therapy Market Projected to Reach US$ 309.60 – GlobeNewswire

Global exosome therapy market projected to reach $309.60 million as regenerative medicine field expands with promising treatments.

Source: GlobeNewswire

Hormones

March 24, 2026

Why the ‘mad scramble’ to fill hormone therapy prescriptions for menopause – NPR

A surge in demand combined with manufacturing issues has created widespread shortages of menopause hormone therapy prescriptions.

Source: NPR

Hormones

March 24, 2026

Emotional and cognitive effects of menopause and hormone replacement therapy – Cambridge University Press & Assessment

New Cambridge research examines how menopause and HRT affect memory, concentration, and emotional well-being in women.

Source: Cambridge University Press & Assessment

GLP-1

March 24, 2026

GLP-1 Weight Loss Drugs Found to Have Mental Health Benefits, According to New Study – People.com

New research suggests GLP-1 weight loss medications may provide mental health benefits beyond their metabolic effects.

Source: People.com

GLP-1

March 24, 2026

Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs | Newswise – Newswise

New data shows type 1 diabetes patients using GLP-1 drugs experience improved heart and kidney health outcomes.

Source: Newswise

Hormones

March 23, 2026

HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy – HHS.gov

HHS removes FDA warnings on hormone replacement therapy, calling them misleading and urging more balanced menopause treatment guidance.

Source: HHS.gov

Peptides

March 23, 2026

The peptide genomic therapy increases antibacterial immunity and survival in sepsis by reprograming the gene orthologs of human immunodeficiencies in the spleen and lungs – Frontiers

New peptide therapy boosts survival in sepsis by correcting immune system genes in the spleen and lungs, researchers report.

Source: Frontiers

Peptides

March 23, 2026

The T&C Know-It-All’s Guide to… The Great Peptide Push – Town & Country Magazine

Peptides have become the latest luxury wellness trend, though experts warn many products lack regulatory oversight and clinical evidence.

Source: Town & Country Magazine

GLP-1

March 23, 2026

Stopping GLP-1 drugs can quickly erase cardiovascular benefits – WashU Medicine

WashU Medicine research shows cardiovascular benefits from GLP-1 drugs quickly vanish after stopping treatment, raising concerns about adherence.

Source: WashU Medicine

GLP-1

March 23, 2026

Indian drugmakers flood market with cheaper versions of Novo’s Ozempic, Wegovy – Reuters

Indian pharma companies are releasing low-cost alternatives to Novo Nordisk's semaglutide drugs at fraction of branded prices.

Source: Reuters

GLP-1

March 23, 2026

As Demand for GLP-1 Pills and Shots Surges, Healthy Habits Are Still Key – U.S. News & World Report

Experts emphasize diet and exercise remain crucial despite surging demand for GLP-1 weight loss medications like Ozempic and Wegovy.

Source: U.S. News & World Report

Cellular Health

March 23, 2026

Do NAD+ supplements work to promote longevity? Here’s what the experts say. – National Geographic

Experts caution that while NAD+ supplements boost cellular markers, evidence for actual anti-aging benefits in humans remains limited.

Source: National Geographic

Hormones

March 23, 2026

Is HRT in menopause healthy? US label change triggers debate – Nature

FDA label updates for menopause hormone therapy renew scientific debate about treatment risks and benefits for millions of women.

Source: Nature

Peptides

March 23, 2026

The Soft Launch Into Longevity: Three Smart Ways to Start Peptide Therapy | Celebrity News | Haute MD Network – Haute Living

Haute MD Network outlines three strategic entry points for beginning peptide therapy focused on longevity and wellness optimization.

Source: Haute Living

GLP-1

March 23, 2026

Ozempic copies for $14 as the generic GLP-1 era starts in India – Los Angeles Times

Generic semaglutide now sells for $14 monthly in India, a fraction of U.S. prices for Ozempic and Wegovy.

Source: Los Angeles Times

Aesthetics

March 20, 2026

Positive topline results show Botox Cosmetic may improve aesthetics of platysma prominence – Healio

Clinical trial shows Botox Cosmetic may effectively treat visible neck bands caused by platysma muscle prominence.

Source: Healio

Hormones

March 20, 2026

Emotional and cognitive effects of menopause and hormone replacement therapy | Psychological Medicine – Cambridge University Press & Assessment

New review examines how menopause affects mood and cognition, and whether hormone therapy can help preserve mental function.

Source: Cambridge University Press & Assessment

Hormones

March 20, 2026

What Is the Lowest Dose of Estrogen for Menopause? – HealthCentral

Low-dose estrogen therapy for menopause can start as low as 0.014 mg, offering symptom relief with potentially reduced risks.

Source: HealthCentral

GLP-1

March 20, 2026

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program – Cardiovascular Business

Recent developments regarding another win for wegovy: fda approves higher semaglutide dose as part of new pilot program - cardiovascular business have draw

Source: Cardiovascular Business

GLP-1

March 20, 2026

Recently Approved Wegovy Pill Expands Access to GLP-1 Therapy for Chronic Weight Management – Pharmacy Times

FDA approves oral Wegovy pill, offering needle-free GLP-1 option for weight management alongside existing injection therapy.

Source: Pharmacy Times

Peptides

March 19, 2026

Influencers are promoting peptides for better health. What does the science say? – NPR

Influencers promote peptides for wellness, but NPR finds scientific evidence lags far behind the social media hype and claims.

Source: NPR

GLP-1

March 19, 2026

STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.

FDA approves high-dose Wegovy, expanding Novo Nordisk's obesity treatment options amid surging demand for GLP-1 medications.

Source: statnews.com

Aesthetics

March 19, 2026

Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China – PR Newswire

Allergan launches BOTOX® Cosmetic for masseter muscle reduction in China, offering non-surgical jawline contouring.

Source: PR Newswire

Exosomes

March 19, 2026

Deer antler stem cell-derived exosomes: a regenerative medicine powerhouse from nature’s own repair kit – Frontiers

Deer antler stem cell exosomes show promise for regenerative medicine, harnessing nature's fastest-growing tissue for human therapy.

Source: Frontiers

Peptides

March 19, 2026

Sermorelin.com Launches New Peptide Therapy Program for GLP-1 Patients – Knoxville News Sentinel

Sermorelin.com introduces peptide therapy program targeting patients on GLP-1 medications for weight management and metabolic health.

Source: Knoxville News Sentinel

GLP-1

March 19, 2026

Axios-Ipsos poll: Cost isn’t discouraging GLP-1 use

New Axios-Ipsos polling shows Americans are accessing GLP-1 medications despite high costs, with perceived health benefits outweighing financial concerns.

Source: Axios

Exosomes

March 19, 2026

Role of exosome therapy in reconstructive surgery: a review

Exosome therapy shows promise in reconstructive surgery by enhancing tissue healing, reducing scarring, and improving graft survival rates.

Source: Frontiers

Hormones

March 19, 2026

Does Testosterone Help Perimenopause Symptoms?

Research suggests testosterone therapy may address specific perimenopausal symptoms, though experts emphasize careful evaluation and monitoring are essenti

Source: Everyday Health

Aesthetics

March 19, 2026

Positive topline results show Botox Cosmetic may improve aesthetics of platysma prominence

Phase 3 trial shows Botox Cosmetic significantly improved appearance of moderate to severe neck bands compared to placebo in adults.

Source: Healio

GLP-1

March 19, 2026

Stopping GLP-1 drugs can quickly erase cardiovascular benefits

New data shows cardiovascular improvements from GLP-1 medications may reverse within weeks of stopping treatment, raising concerns about long-term care.

Source: WashU Medicine

Peptides

March 19, 2026

Cascade Therapy of Periodontitis via Sequential Release of Ribosome-Targeting Antimicrobial Peptide and Irisin From a Multifunctional MOF-Based System – Wiley

New MOF-based system delivers antimicrobial peptides and irisin sequentially to fight gum disease and promote tissue healing.

Source: Wiley

Aesthetics

March 18, 2026

Aesthetic Neurotoxin Market Size, Share | Growth Report [2034] – Fortune Business Insights

New market analysis forecasts significant growth for aesthetic neurotoxin treatments through 2034 as demand for non-surgical procedures rises.

Source: Fortune Business Insights

Exosomes

March 18, 2026

Multifaceted mechanisms and targeted delivery of mesenchymal stem cell-derived exosomes in cardiovascular diseases: a translational medicine perspective – Frontiers

New review explores how engineered exosomes from stem cells could deliver targeted regenerative therapy for heart disease patients.

Source: Frontiers

Hormones

March 18, 2026

Menopause: HRT may boost weight loss, protect bone health – Medical News Today

Research shows hormone replacement therapy may help menopausal women lose weight while protecting bone density during hormonal transition.

Source: Medical News Today

Hormones

March 18, 2026

The truth about hormone therapy, what women long called HRT, for menopause – UCHealth

UCHealth clarifies modern hormone therapy benefits for menopause, countering confusion from decades-old studies about treatment risks.

Source: UCHealth

Peptides

March 18, 2026

Injectable peptide therapy went mainstream in 2025, priming consumers for the next big wellness wave – glossy.co

Injectable peptide therapies moved into mainstream consumer markets in 2025, building on comfort established by GLP-1 medications.

Source: glossy.co

Peptides

March 18, 2026

Why the FDA regulations on peptide therapy matter – KevinMD.com

FDA intensifies scrutiny of compounded peptide therapies, citing safety concerns and manufacturing standards that affect thousands of patients.

Source: KevinMD.com

GLP-1

March 18, 2026

Why quitting Ozempic and GLP-1s can be bad for your heart health – USA Today

Stopping Ozempic and similar GLP-1 drugs may reverse cardiovascular benefits, raising heart attack and stroke risks for patients.

Source: USA Today

GLP-1

March 18, 2026

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect – Eli Lilly

Eli Lilly expands Zepbound access with self-pay pricing at major retail pharmacies beyond LillyDirect platform.

Source: Eli Lilly

GLP-1

March 18, 2026

The GLP-1 saga is only getting juicier and messier

New controversies around pricing, access, and compounding practices complicate the GLP-1 medication landscape.

Source: Scientific American

Hormones

March 18, 2026

Ohio bill would require insurers to cover menopause treatment

Ohio legislators consider bill requiring insurers to cover menopause treatments including hormone therapy and counseling services.

Source: The Columbus Dispatch

Exosomes

March 18, 2026

Exosome Therapy Market Size to Hit USD 307.04 Billion by 2035

The exosome therapy market is projected to reach $307 billion by 2035 as research into cell-derived vesicles expands across disease areas.

Source: Precedence Research

Exosomes

March 18, 2026

The therapeutic effect of exosomes in type 2 diabetes mellitus and its complications

New research explores how exosomes may offer therapeutic benefits for type 2 diabetes and its complications.

Source: Frontiers

GLP-1

March 18, 2026

Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight

Indian manufacturers are producing weight-loss drugs similar to Ozempic for $5-40 monthly versus $1,000 in the US.

Source: BBC

Cellular Health

March 17, 2026

Do NAD+ supplements work to promote longevity? Here’s what the experts say.

Experts say evidence for NAD+ supplements' anti-aging benefits remains thin despite a booming market worth hundreds of millions.

Source: National Geographic

GLP-1

March 17, 2026

Semaglutide is going off-patent in India. But will people who need it be able to get it?

Semaglutide's patent expiration in India may not guarantee access for patients who need the diabetes drug most.

Source: statnews.com

GLP-1

March 17, 2026

Patients who stop GLP-1 drugs often restart or try alternatives

Many patients who stop GLP-1 medications later restart treatment or switch to alternative formulations.

Source: News-Medical

Peptides

March 17, 2026

Want to hack your body with peptides? If only the science agreed

New analysis reveals peptide wellness claims far outpace scientific evidence, raising safety and efficacy concerns.

Source: The Economist

Peptides

March 17, 2026

Get ready for the peptides gold rush

Pharmaceutical industry prepares for major expansion in peptide therapeutics across multiple disease areas.

Source: Medical Marketing and Media

Peptides

March 16, 2026

Injectable peptide therapy went mainstream in 2025, priming consumers for the next big wellness wave

Injectable peptide therapies surged into mainstream wellness in 2025, expanding beyond medical clinics to widespread consumer use.

Source: glossy.co

Peptides

March 16, 2026

Sermorelin.com Launches New Peptide Therapy Program for GLP-1 Patients

Sermorelin.com introduces peptide program targeting muscle preservation for patients on GLP-1 weight loss medications.

Source: Knoxville News Sentinel

Aesthetics

March 16, 2026

Aesthetic Neurotoxin Market Size, Share | Growth Report [2034]

New market analysis projects strong growth for aesthetic neurotoxin treatments through 2034 amid rising consumer demand.

Source: Fortune Business Insights

GLP-1

March 16, 2026

Structure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trial

Structure Therapeutics' oral GLP-1 shows promising obesity trial results, offering a pill alternative to injectable weight-loss drugs.

Source: BioPharma Dive

Peptides

March 16, 2026

An antimicrobial peptide as a potential therapy for bacterial pneumonia that alleviates antimicrobial resistance

New antimicrobial peptide shows promise against drug-resistant pneumonia by using membrane disruption rather than conventional mechanisms.

Source: Nature

Hormones

March 16, 2026

Menopause: HRT may boost weight loss, protect bone health

Research shows HRT may enhance weight loss and bone density in menopausal women beyond relieving symptoms.

Source: Medical News Today

GLP-1

March 16, 2026

Boston Mayor Wu, City Hall unions battle over ‘skyrocketing’ GLP-1 weight loss drug coverage costs – Boston Herald

Boston Mayor Wu clashes with unions over surging costs of covering GLP-1 weight loss drugs for city employees.

Source: Boston Herald

Hormones

March 16, 2026

Expert Perspective: Why Removing HRT Warning Labels Is a Watershed Moment for Women’s Health

FDA removes decades-old HRT warning labels, enabling evidence-based menopause treatment after years of outdated risk messaging.

Source: WGN Radio 720

Hormones

March 16, 2026

What Patients Need to Know About Hormone Replacement Therapy and Cancer Risk in 2026

New ACS guidance clarifies HRT cancer risks, showing combined therapy poses small breast cancer increase while estrogen-only may protect.

Source: American Cancer Society

Peptides

March 16, 2026

Why FDA Regulations on Peptide Therapy Matter for Patient Safety and Access

FDA's regulatory framework for peptide therapy balances patient safety with treatment access amid growing popularity.

Source: KevinMD.com

Peptides

March 16, 2026

Peptide Therapy Surges in Popularity as Medical Experts Urge Caution on Unregulated Use

Rising peptide therapy popularity prompts medical warnings about unregulated compounds and potential health risks.

Source: The Hindu

GLP-1

March 16, 2026

Eli Lilly Launches Zepbound KwikPen at $399 Self-Pay Price, Undercutting Compounders

Eli Lilly introduces Zepbound KwikPen at $399 monthly, directly challenging compounding pharmacies in the GLP-1 market.

Source: Eli Lilly and Company